These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10534767)

  • 1. Fine-structure deletion mapping of 10q22-24 identifies regions of loss of heterozygosity and suggests that sporadic follicular thyroid adenomas and follicular thyroid carcinomas develop along distinct neoplastic pathways.
    Yeh JJ; Marsh DJ; Zedenius J; Dwight T; Delbridge L; Robinson BG; Eng C
    Genes Chromosomes Cancer; 1999 Dec; 26(4):322-8. PubMed ID: 10534767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors.
    Halachmi N; Halachmi S; Evron E; Cairns P; Okami K; Saji M; Westra WH; Zeiger MA; Jen J; Sidransky D
    Genes Chromosomes Cancer; 1998 Nov; 23(3):239-43. PubMed ID: 9790504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential loss of heterozygosity in the region of the Cowden locus within 10q22-23 in follicular thyroid adenomas and carcinomas.
    Marsh DJ; Zheng Z; Zedenius J; Kremer H; Padberg GW; Larsson C; Longy M; Eng C
    Cancer Res; 1997 Feb; 57(3):500-3. PubMed ID: 9012481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mutation and germline variants of MINPP1, a phosphatase gene located in proximity to PTEN on 10q23.3, in follicular thyroid carcinomas.
    Gimm O; Chi H; Dahia PL; Perren A; Hinze R; Komminoth P; Dralle H; Reynolds PR; Eng C
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1801-5. PubMed ID: 11297621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletions of the long arm of chromosome 10 in progression of follicular thyroid tumors.
    Zedenius J; Wallin G; Svensson A; Bovèe J; Höög A; Bäckdahl M; Larsson C
    Hum Genet; 1996 Mar; 97(3):299-303. PubMed ID: 8786068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.
    Dahia PL; Marsh DJ; Zheng Z; Zedenius J; Komminoth P; Frisk T; Wallin G; Parsons R; Longy M; Larsson C; Eng C
    Cancer Res; 1997 Nov; 57(21):4710-3. PubMed ID: 9354427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation.
    Marsh DJ; Dahia PL; Coulon V; Zheng Z; Dorion-Bonnet F; Call KM; Little R; Lin AY; Eeles RA; Goldstein AM; Hodgson SV; Richardson AL; Robinson BG; Weber HC; Longy M; Eng C
    Genes Chromosomes Cancer; 1998 Jan; 21(1):61-9. PubMed ID: 9443042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas.
    Ward LS; Brenta G; Medvedovic M; Fagin JA
    J Clin Endocrinol Metab; 1998 Feb; 83(2):525-30. PubMed ID: 9467569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.
    Grebe SK; McIver B; Hay ID; Wu PS; Maciel LM; Drabkin HA; Goellner JR; Grant CS; Jenkins RB; Eberhardt NL
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3684-91. PubMed ID: 9360526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sporadic follicular thyroid tumors show loss of a 200-kb region in 11q13 without evidence for mutations in the MEN1 gene.
    Nord B; Larsson C; Wong FK; Wallin G; Teh BT; Zedenius J
    Genes Chromosomes Cancer; 1999 Sep; 26(1):35-9. PubMed ID: 10441003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Loss of heterozygosity on chromosome 3p in thyroid tumors].
    Hu MJ; Xu HD; Zhou R; Li XF; Zhang HY
    Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):305-8. PubMed ID: 18956647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of loss of heterozygosity in imprinted, compared with nonimprinted, genomic regions in follicular thyroid carcinomas and atypical adenomas.
    Sarquis MS; Weber F; Shen L; Broelsch CE; Jhiang SM; Zedenius J; Frilling A; Eng C
    J Clin Endocrinol Metab; 2006 Jan; 91(1):262-9. PubMed ID: 16249278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene.
    Farrand K; Delahunt B; Wang XL; McIver B; Hay ID; Goellner JR; Eberhardt NL; Grebe SK
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4715-21. PubMed ID: 12364463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer.
    Frisk T; Foukakis T; Dwight T; Lundberg J; Höög A; Wallin G; Eng C; Zedenius J; Larsson C
    Genes Chromosomes Cancer; 2002 Sep; 35(1):74-80. PubMed ID: 12203792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors.
    Zhang JS; Nelson M; McIver B; Hay ID; Goellner JR; Grant CS; Eberhardt NL; Smith DI
    Oncogene; 1998 Aug; 17(6):789-93. PubMed ID: 9715281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelotype of follicular thyroid carcinomas reveals genetic instability consistent with frequent nondisjunctional chromosomal loss.
    Tung WS; Shevlin DW; Kaleem Z; Tribune DJ; Wells SA; Goodfellow PJ
    Genes Chromosomes Cancer; 1997 May; 19(1):43-51. PubMed ID: 9135994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelotyping of follicular thyroid tumors.
    Zedenius J; Wallin G; Svensson A; Grimelius L; Höög A; Lundell G; Bäckdahl M; Larsson C
    Hum Genet; 1995 Jul; 96(1):27-32. PubMed ID: 7607650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors.
    Gimm O; Perren A; Weng LP; Marsh DJ; Yeh JJ; Ziebold U; Gil E; Hinze R; Delbridge L; Lees JA; Mutter GL; Robinson BG; Komminoth P; Dralle H; Eng C
    Am J Pathol; 2000 May; 156(5):1693-700. PubMed ID: 10793080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity in follicular and papillary thyroid carcinomas.
    Rodrigues-Serpa A; Catarino A; Soares J
    Cancer Genet Cytogenet; 2003 Feb; 141(1):26-31. PubMed ID: 12581895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinico-pathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: analysis of 318 microdissected thyroid lesions.
    Trovato M; Ulivieri A; Dominici R; Ruggeri RM; Vitarelli E; Benvenga S; Barresi G; Trimarchi F; Brunetti E; Vecchione A; Andreoli M; Sciacchitano S
    Endocr Relat Cancer; 2004 Jun; 11(2):365-76. PubMed ID: 15163311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.